{
    "article_id": "PMC7790993",
    "article_text_type": "fulltext",
    "article_filtered_sentences": [
        "Material and methods - Primary outcome\nThe primary endpoints of this study were (1) to investigate the toxicity profile and tolerability of naproxen at two dose levels over 6 months of therapy; and (2) to determine whether treatment with naproxen once-daily at two different dose levels administered during a period of 6 months as compared with placebo caused a reduction in the concentration of prostaglandin E2 (PGE2) levels in normal colorectal mucosa in the study population evaluated as the percentage of change after treatment from baseline.",
        "Results - Outcomes - Primary outcomes\nAll patients who received the study drug were assessed for toxicity and safety profile."
    ],
    "registry_id": "NCT02052908",
    "registry_primary_outcomes": [
        "Change in PGE2 concentration levels in normal colorectal mucosa , Baseline to 6 months",
        "Minimal biologically effective dose of naproxen defined by modulation of PGE2 levels , Up to 6 months",
        "Response defined as >= 30% reduction in PGE2 levels , Up to 6 months",
        "Incidence of toxicity graded according to National Cancer Institute Common Criteria for Adverse Events (NCI CTCAE) version 4.0 , Up to 6 months"
    ],
    "labels": {
        "POS_identif_possible": "Yes",
        "PO_switch": "Yes",
        "PO_not_reported_registry": "No",
        "PO_not_reported_publication": "Yes",
        "POS_timeframe_metric": "No",
        "Description": ""
    },
    "article_bio_outcomes": [
        {
            "sentence_nb": 0,
            "tokens": [
                "Material",
                "and",
                "methods",
                "-",
                "Primary",
                "outcome",
                "The",
                "primary",
                "endpoints",
                "of",
                "this",
                "study",
                "were",
                "(",
                "1",
                ")",
                "to",
                "investigate",
                "the",
                "toxicity",
                "profile",
                "and",
                "tolerability",
                "of",
                "naproxen",
                "at",
                "two",
                "dose",
                "levels",
                "over",
                "6",
                "months",
                "of",
                "therapy",
                ";",
                "and",
                "(",
                "2",
                ")",
                "to",
                "determine",
                "whether",
                "treatment",
                "with",
                "naproxen",
                "once-daily",
                "at",
                "two",
                "different",
                "dose",
                "levels",
                "administered",
                "during",
                "a",
                "period",
                "of",
                "6",
                "months",
                "as",
                "compared",
                "with",
                "placebo",
                "caused",
                "a",
                "reduction",
                "in",
                "the",
                "concentration",
                "of",
                "prostaglandin",
                "E2",
                "(",
                "PGE2",
                ")",
                "levels",
                "in",
                "normal",
                "colorectal",
                "mucosa",
                "in",
                "the",
                "study",
                "population",
                "evaluated",
                "as",
                "the",
                "percentage",
                "of",
                "change",
                "after",
                "treatment",
                "from",
                "baseline",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        },
        {
            "sentence_nb": 1,
            "tokens": [
                "Results",
                "-",
                "Outcomes",
                "-",
                "Primary",
                "outcomes",
                "All",
                "patients",
                "who",
                "received",
                "the",
                "study",
                "drug",
                "were",
                "assessed",
                "for",
                "toxicity",
                "and",
                "safety",
                "profile",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        }
    ],
    "article_outcomes_text": [
        "toxicity profile and tolerability of naproxen at two dose levels over 6 months of therapy",
        "toxicity and safety profile",
        "reduction in the concentration of prostaglandin E2 ( PGE2 ) levels in normal colorectal mucosa in the study population evaluated as the percentage of change after treatment from baseline"
    ],
    "article2article_connections": [
        [
            0,
            1,
            true
        ],
        [
            0,
            2,
            false
        ],
        [
            1,
            2,
            false
        ]
    ],
    "filtered_article_outcomes": [
        "toxicity profile and tolerability of naproxen at two dose levels over 6 months of therapy",
        "reduction in the concentration of prostaglandin E2 ( PGE2 ) levels in normal colorectal mucosa in the study population evaluated as the percentage of change after treatment from baseline"
    ],
    "article2registry_connections": [
        {
            "article_index": 0,
            "registry_index": 0,
            "similar": false
        },
        {
            "article_index": 0,
            "registry_index": 1,
            "similar": false
        },
        {
            "article_index": 0,
            "registry_index": 2,
            "similar": false
        },
        {
            "article_index": 0,
            "registry_index": 3,
            "similar": true
        },
        {
            "article_index": 1,
            "registry_index": 0,
            "similar": true
        },
        {
            "article_index": 1,
            "registry_index": 1,
            "similar": true
        },
        {
            "article_index": 1,
            "registry_index": 2,
            "similar": true
        },
        {
            "article_index": 1,
            "registry_index": 3,
            "similar": false
        }
    ]
}